e-Drug3D

1245

BUTOCONAZOLE


INN
BUTOCONAZOLE

cas 64872-76-0
CLASS

GENITO
ANTIFUNGAL
INHIBITION OF STEROID SYNTHESIS (INHIBITION OF CONVERSION OF LANOSTEROL TO ERGOSTEROL)

ROUTE (list)

VAGINAL

ATC code

G01AF15

PK parameters

F 2 PERCENT
Tmax 18 HOUR

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET LANOSTEROL 14 ALPHA-DEMETHYLASE

DrugCentral

Lanosterol 14-alpha demethylase UNIPROT P10613 ERG11

Download SDF file 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole

Formula:
C19H17Cl3N2S

Calculated chemical properties:

MW 411.77
NB_atoms 25
XLogP 6.64
PSA 13.678
NB_HD 0
NB_HA 2
fsp3 0.21
Lipinski(0=no;1=yes) 0

FDA
NDA 019215 (pdf not found) INN (BUTOCONAZOLE NITRATE) FEMSTAT (ROCHE PALO) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 019359 (pdf not found) INN (BUTOCONAZOLE NITRATE) FEMSTAT (ROCHE PALO) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 020421 (pdf not found) INN (BUTOCONAZOLE NITRATE) FEMSTAT 3 (BAYER) APPROVAL= AP YEAR= 1995 DISCONTINUED
NDA 019881 (label) INN (BUTOCONAZOLE NITRATE) BUTOCONAZOLE NITRATE (PADAGIS US) APPROVAL= AP YEAR= 1997 DISCONTINUED
NDA 200923 (pdf not found) INN (BUTOCONAZOLE NITRATE) GYNAZOLE-1 (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2012

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL